Our Breast Pathology team currently diagnoses and evaluates more than 1,200 new cases of breast cancer per year.  As an integral member of the multidisciplinary cancer treatment team, we work closely with surgeons, radiologists and oncologists, to provide them with prompt and accurate diagnoses and various prognostic markers, which aid in the design of the final treatment plan.  The services we offer provide gross, including intraoperative, and microscopic examination of different types of specimens, including fine needle aspiration, needle core biopsies, lumpectomies and mastectomies with or without sentinel lymph node evaluation/axillary dissection.  Our Breast Pathology sub-specialty is led by Dr. Nan Ping Wang, CellNetix Director of Immunohistochemistry.

Our Strengths

CellNetix’ quality program mandates that all new cancers are reviewed by a second pathologist for quality assurance. All breast excision specimens are thoroughly evaluated following a standard protocol with standardized pathology reporting format in compliance with College of American Pathologists (CAP) guidelines. Our state-of-the-art bar-coding system has been shown to reduce common histologic slide identification errors by 95% and overall case identification errors by 62%. 

• Six board certified pathologists with expertise in Breast Pathology
• Weekly participation in multidisciplinary breast conferences provides opportunities to review and consult on many unusual and difficult cases
• 94% of our biopsy results are returned within 48 hours
• 24/7 priority access to your local pathologists
• Standardized gross evaluation and sampling protocol for all breast excision specimens
• Standardized format of pathology reports convey information clearly, concisely and correctly
• Standardized protocol for sentinel lymph node evaluation, including intra-operative consultation and immunostain.
• State-of-the-art Information Technology systems with EMR interface capabilities
• Full service billing department for direct billing of patient insurance, as well as payment plans for cash-paying patients
• Customizable test requisitions
• Customized monthly data summaries to assist physicians’ staff with scheduling follow up visits and managing patient care

Our Breast Pathologists are available to provide their expertise for questions, evaluations and second opinions on all cases pertaining to their specialty.

Types of Testing We Do

• Consultation (Second Opinion) on outside pathology slides
• Immunohistochemistry evaluation of various breast cancer prognostic markers, including, but not limited to,
  • estrogen receptor,
  • progesterone receptor, and
  • HER2/neu

Types of Conditions and Diseases We Test For

• All “lumps and bumps” in breast or any radiographic (mammographic or MRI) abnormalities, such as calcifications or architectural distortion